BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2676994)

  • 1. Relation of serum molindone levels to serum prolactin levels and antipsychotic response.
    Pandurangi AK; Narasimhachari N; Blackard WG; Landa BS
    J Clin Psychiatry; 1989 Oct; 50(10):379-81. PubMed ID: 2676994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of clinical and laboratory experiences with molindone hydrochloride.
    Claghorn JL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):30-3. PubMed ID: 3894340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
    Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB
    J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between psychotic symptoms and serum prolactin levels.
    Roncoroni D
    Pharmacopsychiatry; 1989 Mar; 22(2):71-5. PubMed ID: 2566181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA
    J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with molindone hydrochloride in geriatric patients.
    Peper M
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):26-9. PubMed ID: 3894339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.
    Melkersson KI
    Hum Psychopharmacol; 2006 Dec; 21(8):529-32. PubMed ID: 17094165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics.
    Escobar JI; Mann JJ; Keller J; Wilkins J; Mason B; Mills MJ
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):15-9. PubMed ID: 3894337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient.
    Binder R; Glick I; Rice M
    J Clin Psychiatry; 1981 May; 42(5):203-6. PubMed ID: 7217025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trifluoperazine plasma levels and clinical response.
    Janicak PG; Javaid JI; Sharma RP; Comaty JE; Peterson J; Davis JM
    J Clin Psychopharmacol; 1989 Oct; 9(5):340-6. PubMed ID: 2794098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response.
    Lostia AM; Mazzarini L; Pacchiarotti I; Lionetto L; De Rossi P; Sanna L; Sani G; Kotzalidis GD; Girardi P; Simmaco M; Tatarelli R
    Ther Drug Monit; 2009 Aug; 31(4):475-81. PubMed ID: 19531984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molindone hydrochloride: a review of laboratory and clinical findings.
    Owen RR; Cole JO
    J Clin Psychopharmacol; 1989 Aug; 9(4):268-76. PubMed ID: 2671060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O; Weiner RD; McEvoy JP
    Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term study of molindone hydrochloride in chronic schizophrenics.
    Kellner R; Rada RT; Egelman A; Macaluso B
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):686-94. PubMed ID: 825355
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of oral and intramuscular molindone hydrochloride in schizophrenic patients.
    Zetin M; Cramer M; Garber D; Plon L; Paulshock M; Hoffman HE; Schary WL
    Clin Ther; 1985; 7(2):169-75. PubMed ID: 3986861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molindone--a new antipsychotic drug.
    Med Lett Drugs Ther; 1975 Jul; 17(14):59. PubMed ID: 237228
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine, negative symptoms, and extrapyramidal side effects.
    Kane JM; Safferman AZ; Pollack S; Johns C; Szymanski S; Kronig M; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():74-7. PubMed ID: 7961579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.